A man in England with multiple sclerosis can walk and dance for the first time in 10 years after receiving a stem cell transplant for the disease.

Roy Palmer used a wheelchair for the last decade and had no feeling in his legs.

He decided to undergo a procedure known as hematopoietic stem cell transplantation after seeing the results from a television program.

Two days after the procedure, Palmer regained feelings in his legs.

Hematopoietic stem cell transplantation is still considered experimental and can result in side effects such as infections and infertility, according to the National Multiple Sclerosis Society.

A man from Gloucester, England, can walk and dance for the first time in 10 years after receiving a revolutionary stem cell transplant for his multiple sclerosis, CBS News reported on Wednesday.

Roy Palmer, a 49-year-old man who used a wheelchair, opted to undergo the treatment known as hematopoietic stem cell transplantation after watching a BBC program that showed the results of the treatment.

Palmer reportedly regained feeling in his legs two days after the procedure.

Hematopoietic stem cell transplantation, which uses stem cells to "reboot" the immune system, is still considered to be risky by the National Multiple Sclerosis Society. The treatment, which is reportedly still in its experimental stages and has not been approved by the Food and Drug Administration, may result in long-term side effects such as infections and infertility.

Multiple sclerosis is a disorder in which the bodily systems that are supposed to keep people healthy mistakenly attack the protective covering of nerves. This results in damage to the communication between the spinal cord and brain, according to Healthline.com. In severe cases like Palmer's, the disease can result in paralysis, vision loss, and lessened brain functions.

"They take the stem cells out of your body," Palmer said to the BBC. "They give you chemotherapy to kill the rest of your immune system."

There are about 2.3 million people living with multiple sclerosis around the world, Healthline reported. Researchers have yet to identify the cause of the disease.